{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:04:34Z","timestamp":1767027874476,"version":"3.48.0"},"reference-count":53,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274367"],"award-info":[{"award-number":["82274367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Plan of Hubei Provincial Department of Education","award":["Q20222003"],"award-info":[{"award-number":["Q20222003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that causes bile duct damage, liver fibrosis, and cirrhosis, significantly affecting patients\u2019 lives and healthcare costs. Early diagnosis is critical but is hindered by the limited sensitivity of existing biomarkers, particularly in patients who are negative for anti-mitochondrial antibodies. This limitation underscores the need for more reliable biomarkers. Our study focuses on secretory proteins as potential diagnostic biomarkers and aims to elucidate gene expression profiles associated with PBC using bioinformatics methods and machine learning. We identified 827 downregulated and 639 upregulated genes related to mitochondrial function and immune pathways. Additionally, Weighted Gene Co-expression Network Analysis revealed a blue module comprising 1,949 genes linked to PBC. Machine learning identified between 14 and 18 key diagnostic genes. Using a Gaussian Mixture Model, we achieved an area under the curve of 0.96, indicating excellent diagnostic performance. Notable genes included the upregulated CSF1R, PLCH2, and SLC38A1, as well as the downregulated CST7. Animal experiments further supported these bioinformatics findings. Our research highlights secretory proteins as promising biomarkers for the early diagnosis of PBC, with potential applications in developing precise diagnostic tools and personalized therapies. This work paves the way for future studies involving larger cohorts and multi-omics\u00a0data.<\/jats:p>","DOI":"10.1515\/biol-2025-1192","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:01:18Z","timestamp":1767027678000},"source":"Crossref","is-referenced-by-count":0,"title":["Identification of secretory protein related biomarkers for primary biliary cholangitis based on machine learning and experimental validation"],"prefix":"10.1515","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7120-9321","authenticated-orcid":false,"given":"Zihao","family":"Xu","sequence":"first","affiliation":[{"name":"School of Chinese Medicine, Hubei University of Chinese Medicine , Wuhan , Hubei , 430065 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Cai","sequence":"additional","affiliation":[{"name":"Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , Hubei , 430061 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Hubei University of Chinese Medicine , Wuhan , Hubei , 430065 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[{"name":"Hubei University of Traditional Chinese Medicine , Wuhan , Hubei , 430065 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , Hubei , 430061 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1482-9008","authenticated-orcid":false,"given":"Lihan","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Hubei University of Chinese Medicine , Wuhan , Hubei , 430065 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ji","sequence":"additional","affiliation":[{"name":"Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , Hubei , 430061 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhan","sequence":"additional","affiliation":[{"name":"Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , Hubei , 430061 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangbin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Hubei University of Traditional Chinese Medicine , Wuhan , Hubei , 430065 , China"},{"name":"Hubei Provincial Hospital of Traditional Chinese Medicine , Wuhan , Hubei , 430061 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2025122917011239157_j_biol-2025-1192_ref_001","doi-asserted-by":"crossref","unstructured":"Levy, C, Manns, M, Hirschfield, G. New treatment paradigms in primary biliary cholangitis. Clin Gastroenterol Hepatol 2023;21:2076\u201387. https:\/\/doi.org\/10.1016\/j.cgh.2023.02.005.","DOI":"10.1016\/j.cgh.2023.02.005"},{"key":"2025122917011239157_j_biol-2025-1192_ref_002","doi-asserted-by":"crossref","unstructured":"Sarcognato, S, Sacchi, D, Grillo, F, Cazzagon, N, Fabris, L, Cadamuro, M, et al.. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica 2021;113:170\u201384. https:\/\/doi.org\/10.32074\/1591-951X-245.","DOI":"10.32074\/1591-951X-245"},{"key":"2025122917011239157_j_biol-2025-1192_ref_003","doi-asserted-by":"crossref","unstructured":"Lleo, A, Wang, GQ, Gershwin, ME, Hirschfield, GM. Primary biliary cholangitis. Lancet 2020;396:1915\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(20)31607-X.","DOI":"10.1016\/S0140-6736(20)31607-X"},{"key":"2025122917011239157_j_biol-2025-1192_ref_004","doi-asserted-by":"crossref","unstructured":"Gulamhusein, AF, Hirschfield, GM. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol 2020;17:93\u2013110. https:\/\/doi.org\/10.1038\/s41575-019-0226-7.","DOI":"10.1038\/s41575-019-0226-7"},{"key":"2025122917011239157_j_biol-2025-1192_ref_005","doi-asserted-by":"crossref","unstructured":"Trivella, J, John, BV, Levy, C. Primary biliary cholangitis: epidemiology, prognosis, and treatment. Hepatol Commun 2023;7:e0179. https:\/\/doi.org\/10.1097\/HC9.0000000000000179.","DOI":"10.1097\/HC9.0000000000000179"},{"key":"2025122917011239157_j_biol-2025-1192_ref_006","doi-asserted-by":"crossref","unstructured":"Akamatsu, N, Sugawara, Y. Primary biliary cirrhosis and liver transplantation. Intractable Rare Dis Res 2012;1:66\u201380. https:\/\/doi.org\/10.5582\/irdr.2012.v1.2.66.","DOI":"10.5582\/irdr.2012.v1.2.66"},{"key":"2025122917011239157_j_biol-2025-1192_ref_007","doi-asserted-by":"crossref","unstructured":"Prieto, J, Banales, JM, Medina, JF. Primary biliary cholangitis: pathogenic mechanisms: pathogenic mechanisms. Curr Opin Gastroenterol 2021;37:91\u20138. https:\/\/doi.org\/10.1097\/MOG.0000000000000703.","DOI":"10.1097\/MOG.0000000000000703"},{"key":"2025122917011239157_j_biol-2025-1192_ref_008","doi-asserted-by":"crossref","unstructured":"Li, H, Guan, Y, Han, C, Zhang, Y, Liu, Q, Wei, W, et al.. The pathogenesis, models and therapeutic advances of primary biliary cholangitis. Biomed Pharmacother 2021;140:111754. https:\/\/doi.org\/10.1016\/j.biopha.2021.111754.","DOI":"10.1016\/j.biopha.2021.111754"},{"key":"2025122917011239157_j_biol-2025-1192_ref_009","doi-asserted-by":"crossref","unstructured":"Zhao, Y, Wei, S, Chen, L, Zhou, X, Ma, X. Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products. Front Immunol 2023;14:1164202. https:\/\/doi.org\/10.3389\/fimmu.2023.1164202.","DOI":"10.3389\/fimmu.2023.1164202"},{"key":"2025122917011239157_j_biol-2025-1192_ref_010","doi-asserted-by":"crossref","unstructured":"Pham, HN, Pham, L, Sato, K. Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis. PLoS One 2023;18:e0292998. https:\/\/doi.org\/10.1371\/journal.pone.0292998.","DOI":"10.1371\/journal.pone.0292998"},{"key":"2025122917011239157_j_biol-2025-1192_ref_011","doi-asserted-by":"crossref","unstructured":"Wang, H, Zhang, J, Liu, J, Jiang, Y, Fu, L, Peng, S. Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation. Front Mol Biosci 2023;10:1124956. https:\/\/doi.org\/10.3389\/fmolb.2023.1124956.","DOI":"10.3389\/fmolb.2023.1124956"},{"key":"2025122917011239157_j_biol-2025-1192_ref_012","doi-asserted-by":"crossref","unstructured":"Wakabayashi, K, Lian, ZX, Leung, PSC, Moritoki, Y, Tsuneyama, K, Kurth, MJ, et al.. Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008;48:531\u201340. https:\/\/doi.org\/10.1002\/hep.22390.","DOI":"10.1002\/hep.22390"},{"key":"2025122917011239157_j_biol-2025-1192_ref_013","doi-asserted-by":"crossref","unstructured":"Men, X, Liu, Y, Zhao, H, Xie, B, Guo, C, Leung, PSC, et al.. The treatment of primary biliary cholangitis: time for personalized medicine. Clin Rev Allergy Immunol 2025;68:63. https:\/\/doi.org\/10.1007\/s12016-025-09074-x.","DOI":"10.1007\/s12016-025-09074-x"},{"key":"2025122917011239157_j_biol-2025-1192_ref_014","doi-asserted-by":"crossref","unstructured":"Arndtz, K, Hirschfield, GM. The pathogenesis of autoimmune liver disease. Dig Dis 2016;34:327\u201333. https:\/\/doi.org\/10.1159\/000444471.","DOI":"10.1159\/000444471"},{"key":"2025122917011239157_j_biol-2025-1192_ref_015","doi-asserted-by":"crossref","unstructured":"Yang, Y, He, X, Rojas, M, Leung, PSC, Gao, L. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? Front Immunol 2023;14:1184252. https:\/\/doi.org\/10.3389\/fimmu.2023.1184252.","DOI":"10.3389\/fimmu.2023.1184252"},{"key":"2025122917011239157_j_biol-2025-1192_ref_016","doi-asserted-by":"crossref","unstructured":"Can\u00e7ado, GGL, Lleo, A, Levy, C, Trauner, M, Hirschfield, GM. Primary biliary cholangitis and the narrowing gap towards optimal disease control. Lancet Gastroenterol Hepatol 2025;10:855\u201370. https:\/\/doi.org\/10.1016\/S2468-1253(25)00025-1.","DOI":"10.1016\/S2468-1253(25)00025-1"},{"key":"2025122917011239157_j_biol-2025-1192_ref_017","doi-asserted-by":"crossref","unstructured":"Hollingsworth, KG, Newton, JL, Taylor, R, McDonald, C, Palmer, JM, Blamire, AM, et al.. Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis. Clin Gastroenterol Hepatol 2008;6:1041\u20138. https:\/\/doi.org\/10.1016\/j.cgh.2008.04.013.","DOI":"10.1016\/j.cgh.2008.04.013"},{"key":"2025122917011239157_j_biol-2025-1192_ref_018","doi-asserted-by":"crossref","unstructured":"Xu, Q, Zhu, W, Yin, Y. Diagnostic value of anti-mitochondrial antibody in patients with primary biliary cholangitis: a systemic review and meta-analysis. Medicine (Baltim) 2023;102:e36039. https:\/\/doi.org\/10.1097\/MD.0000000000036039.","DOI":"10.1097\/MD.0000000000036039"},{"key":"2025122917011239157_j_biol-2025-1192_ref_019","doi-asserted-by":"crossref","unstructured":"Hao, J, Yang, T, Zhou, Y, Gao, GY, Xing, F, Peng, Y, et al.. Serum metabolomics analysis reveals a distinct metabolic profile of patients with primary biliary cholangitis. Sci Rep 2017;7:784. https:\/\/doi.org\/10.1038\/s41598-017-00944-9.","DOI":"10.1038\/s41598-017-00944-9"},{"key":"2025122917011239157_j_biol-2025-1192_ref_020","doi-asserted-by":"crossref","unstructured":"Dubreuil, MM, Morgens, DW, Okumoto, K, Honsho, M, Contrepois, K, Lee-McMullen, B, et al.. Systematic identification of regulators of oxidative stress reveals non-canonical roles for peroxisomal import and the pentose phosphate pathway. Cell Rep 2020;30:1417\u201333.e7. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.013.","DOI":"10.1016\/j.celrep.2020.01.013"},{"key":"2025122917011239157_j_biol-2025-1192_ref_021","doi-asserted-by":"crossref","unstructured":"Rusz, M, Del Favero, G, El Abiead, Y, Gerner, C, Keppler, BK, Jakupec, MA, et al.. Morpho-metabotyping the oxidative stress response. Sci Rep 2021;11:15471. https:\/\/doi.org\/10.1038\/s41598-021-94585-8.","DOI":"10.1038\/s41598-021-94585-8"},{"key":"2025122917011239157_j_biol-2025-1192_ref_022","doi-asserted-by":"crossref","unstructured":"Afzal, S, Abdul Manap, AS, Attiq, A, Albokhadaim, I, Kandeel, M, Alhojaily, SM. From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Front Pharmacol 2023;14:1269581. https:\/\/doi.org\/10.3389\/fphar.2023.1269581.","DOI":"10.3389\/fphar.2023.1269581"},{"key":"2025122917011239157_j_biol-2025-1192_ref_023","unstructured":"Ross, MK, Raji, C, Lokken, KL, Bredesen, DE, Roach, JC, Funk, CC, et al.. Case study: a precision medicine approach to multifactorial dementia and Alzheimer\u2019s disease. J\u00a0Alzheimers Dis Parkinsonism 2021;11:018."},{"key":"2025122917011239157_j_biol-2025-1192_ref_024","doi-asserted-by":"crossref","unstructured":"Grover, VPB, Southern, L, Dyson, JK, Kim, JU, Crossey, MME, Wylezinska-Arridge, M, et al.. Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging. Aliment Pharmacol Ther 2016;44:936\u201345. https:\/\/doi.org\/10.1111\/apt.13797.","DOI":"10.1111\/apt.13797"},{"key":"2025122917011239157_j_biol-2025-1192_ref_025","doi-asserted-by":"crossref","unstructured":"Shi, TY, Zhang, FC. Role of autoimmunity in primary biliary cirrhosis. World J Gastroenterol 2012;18:7141\u20138. https:\/\/doi.org\/10.3748\/wjg.v18.i48.7141.","DOI":"10.3748\/wjg.v18.i48.7141"},{"key":"2025122917011239157_j_biol-2025-1192_ref_026","doi-asserted-by":"crossref","unstructured":"Jin, C, Jiang, P, Zhang, Z, Han, Y, Wen, X, Zheng, L, et al.. Single-cell RNA sequencing reveals the pro-inflammatory roles of liver-resident Th1-like cells in primary biliary cholangitis. Nat Commun 2024;15:8690. https:\/\/doi.org\/10.1038\/s41467-024-53104-9.","DOI":"10.1038\/s41467-024-53104-9"},{"key":"2025122917011239157_j_biol-2025-1192_ref_027","doi-asserted-by":"crossref","unstructured":"Wang, C, Shi, Y, Wang, X, Ma, H, Liu, Q, Gao, Y, et al.. Peroxisome proliferator-activated receptors regulate hepatic immunity and assist in the treatment of primary biliary cholangitis. Front Immunol 2022;13:940688. https:\/\/doi.org\/10.3389\/fimmu.2022.940688.","DOI":"10.3389\/fimmu.2022.940688"},{"key":"2025122917011239157_j_biol-2025-1192_ref_028","doi-asserted-by":"crossref","unstructured":"Tsuneyama, K, Baba, H, Morimoto, Y, Tsunematsu, T, Ogawa, H. Primary biliary cholangitis: its pathological characteristics and immunopathological mechanisms. J\u00a0Med Investig 2017;64:7\u201313. https:\/\/doi.org\/10.2152\/jmi.64.7.","DOI":"10.2152\/jmi.64.7"},{"key":"2025122917011239157_j_biol-2025-1192_ref_029","doi-asserted-by":"crossref","unstructured":"Di Marco, GS, Chasan, AI, Boeckel, GR, Beul, K, Pavenst\u00e4dt, H, Roth, J, et al.. Monocytes as targets for immunomodulation by regional citrate anticoagulation. Int J Mol Sci 2024;25:2900. https:\/\/doi.org\/10.3390\/ijms25052900.","DOI":"10.3390\/ijms25052900"},{"key":"2025122917011239157_j_biol-2025-1192_ref_030","doi-asserted-by":"crossref","unstructured":"Stanley, ER, Chitu, V. CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol 2014;6:a021857. https:\/\/doi.org\/10.1101\/cshperspect.a021857.","DOI":"10.1101\/cshperspect.a021857"},{"key":"2025122917011239157_j_biol-2025-1192_ref_031","doi-asserted-by":"crossref","unstructured":"Hagan, N, Kane, JL, Grover, D, Woodworth, L, Madore, C, Saleh, J, et al.. CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis 2020;11:904. https:\/\/doi.org\/10.1038\/s41419-020-03084-7.","DOI":"10.1038\/s41419-020-03084-7"},{"key":"2025122917011239157_j_biol-2025-1192_ref_032","doi-asserted-by":"crossref","unstructured":"Chen, D, Xiong, L, Zhang, L, Yu, H, Xu, Y, Wang, M, et al.. CSF1R is a prognostic biomarker and correlated with immune cell infiltration in the gastric cancer microenvironment. Pharmgenomics Pers Med 2021;14:445\u201357. https:\/\/doi.org\/10.2147\/PGPM.S301303.","DOI":"10.2147\/PGPM.S301303"},{"key":"2025122917011239157_j_biol-2025-1192_ref_033","doi-asserted-by":"crossref","unstructured":"Wen, Y, Lambrecht, J, Ju, C, Tacke, F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol 2021;18:45\u201356. https:\/\/doi.org\/10.1038\/s41423-020-00558-8.","DOI":"10.1038\/s41423-020-00558-8"},{"key":"2025122917011239157_j_biol-2025-1192_ref_034","doi-asserted-by":"crossref","unstructured":"Sim\u00f3n-Codina, B, Cacho-Pujol, J, Moles, A, Melgar-Lesmes, P. Reprogramming macrophages to treat liver diseases. Hepatology 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000001160.","DOI":"10.1097\/HEP.0000000000001160"},{"key":"2025122917011239157_j_biol-2025-1192_ref_035","doi-asserted-by":"crossref","unstructured":"Mun, SH, Park, PSU, Park-Min, KH. The M-CSF receptor in osteoclasts and beyond. Exp Mol Med 2020;52:1239\u201354. https:\/\/doi.org\/10.1038\/s12276-020-0484-z.","DOI":"10.1038\/s12276-020-0484-z"},{"key":"2025122917011239157_j_biol-2025-1192_ref_036","doi-asserted-by":"crossref","unstructured":"Zong, C, Meng, Y, Ye, F, Yang, X, Li, R, Jiang, J, et al.. AIF1 + CSF1R + MSCs, induced by TNF-\u03b1, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis. Hepatology 2023;78:434\u201351. https:\/\/doi.org\/10.1002\/hep.32738.","DOI":"10.1002\/hep.32738"},{"key":"2025122917011239157_j_biol-2025-1192_ref_037","doi-asserted-by":"crossref","unstructured":"Katan, M, Cockcroft, S. Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane. Essays Biochem 2020;64:513\u201331. https:\/\/doi.org\/10.1042\/EBC20200041.","DOI":"10.1042\/EBC20200041"},{"key":"2025122917011239157_j_biol-2025-1192_ref_038","doi-asserted-by":"crossref","unstructured":"Izquierdo, J-H, Bonilla-Abad\u00eda, F, Ca\u00f1as, CA, Tob\u00f3n, GJ. Calcio, canales, se\u00f1alizaci\u00f3n intracelular y autoinmunidad. Reumatol Clin 2014;10:43\u20137. https:\/\/doi.org\/10.1016\/j.reuma.2013.05.008.","DOI":"10.1016\/j.reuma.2013.05.008"},{"key":"2025122917011239157_j_biol-2025-1192_ref_039","doi-asserted-by":"crossref","unstructured":"Dickson, EJ, Falkenburger, BH, Hille, B. Quantitative properties and receptor reserve of the IP(3) and calcium branch of G(q)-coupled receptor signaling. J\u00a0Gen Physiol 2013;141:521\u201335. https:\/\/doi.org\/10.1085\/jgp.201210886.","DOI":"10.1085\/jgp.201210886"},{"key":"2025122917011239157_j_biol-2025-1192_ref_040","doi-asserted-by":"crossref","unstructured":"Seegren, PV, Harper, LR, Downs, TK, Zhao, X-Y, Viswanathan, SB, Stremska, ME, et al.. Reduced mitochondrial calcium uptake in macrophages is a major driver of inflammaging. Nat Aging 2023;3:796\u2013812. https:\/\/doi.org\/10.1038\/s43587-023-00436-8.","DOI":"10.1038\/s43587-023-00436-8"},{"key":"2025122917011239157_j_biol-2025-1192_ref_041","doi-asserted-by":"crossref","unstructured":"Rao, RK, Samak, G. Bile duct epithelial tight junctions and barrier function. Tissue Barriers 2013;1:e25718. https:\/\/doi.org\/10.4161\/tisb.25718.","DOI":"10.4161\/tisb.25718"},{"key":"2025122917011239157_j_biol-2025-1192_ref_042","doi-asserted-by":"crossref","unstructured":"Gauthier-Coles, G, Vennitti, J, Zhang, Z, Comb, WC, Xing, S, Javed, K, et al.. Quantitative modelling of amino acid transport and homeostasis in mammalian cells. Nat Commun 2021;12:5282. https:\/\/doi.org\/10.1038\/s41467-021-25563-x.","DOI":"10.1038\/s41467-021-25563-x"},{"key":"2025122917011239157_j_biol-2025-1192_ref_043","doi-asserted-by":"crossref","unstructured":"Qureshi, T, S\u00f8rensen, C, Berghuis, P, Jensen, V, Dobszay, MB, Farkas, T, et al.. The glutamine transporter Slc38a1 regulates GABAergic neurotransmission and synaptic plasticity. Cerebr Cortex 2019;29:5166\u201379. https:\/\/doi.org\/10.1093\/cercor\/bhz055.","DOI":"10.1093\/cercor\/bhz055"},{"key":"2025122917011239157_j_biol-2025-1192_ref_044","doi-asserted-by":"crossref","unstructured":"Blitek, A, Szymanska, M. Regulation of expression and role of peroxisome proliferator-activated receptors (PPARs) in luminal epithelial and stromal cells of the porcine endometrium. Theriogenology 2019;127:88\u2013101. https:\/\/doi.org\/10.1016\/j.theriogenology.2019.01.002.","DOI":"10.1016\/j.theriogenology.2019.01.002"},{"key":"2025122917011239157_j_biol-2025-1192_ref_045","doi-asserted-by":"crossref","unstructured":"Xiao, Y, Hu, B, Guo, Y, Zhang, D, Zhao, Y, Chen, Y, et al.. Targeting glutamine metabolism as an attractive therapeutic strategy for acute myeloid leukemia. Curr Treat Options Oncol 2023;24:1021\u201335. https:\/\/doi.org\/10.1007\/s11864-023-01104-0.","DOI":"10.1007\/s11864-023-01104-0"},{"key":"2025122917011239157_j_biol-2025-1192_ref_046","doi-asserted-by":"crossref","unstructured":"Nwosu, ZC, Megger, DA, Hammad, S, Sitek, B, Roessler, S, Ebert, MP, et al.. Identification of the consistently altered metabolic targets in human hepatocellular carcinoma. Cell Mol Gastroenterol Hepatol 2017;4:303\u201323.e1. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.05.004.","DOI":"10.1016\/j.jcmgh.2017.05.004"},{"key":"2025122917011239157_j_biol-2025-1192_ref_047","doi-asserted-by":"crossref","unstructured":"Sawyer, AJ, Garand, M, Chaussabel, D, Feng, CG. Transcriptomic profiling identifies neutrophil-specific upregulation of cystatin F as a marker of acute inflammation in humans. Front Immunol 2021;12:634119. https:\/\/doi.org\/10.3389\/fimmu.2021.634119.","DOI":"10.3389\/fimmu.2021.634119"},{"key":"2025122917011239157_j_biol-2025-1192_ref_048","doi-asserted-by":"crossref","unstructured":"Jiang, Z, Luo, Y, Wei, L, Gu, R, Zhang, X, Zhou, Y, et al.. Bioinformatic analysis and machine learning methods in neonatal sepsis: identification of biomarkers and immune infiltration. Biomedicines 2023;11:1853. https:\/\/doi.org\/10.3390\/biomedicines11071853.","DOI":"10.3390\/biomedicines11071853"},{"key":"2025122917011239157_j_biol-2025-1192_ref_049","doi-asserted-by":"crossref","unstructured":"Chen, J, Zhang, S. The role of inflammation in cholestatic liver injury. J\u00a0Inflamm Res 2023;16:4527\u201340. https:\/\/doi.org\/10.2147\/JIR.S430730.","DOI":"10.2147\/JIR.S430730"},{"key":"2025122917011239157_j_biol-2025-1192_ref_050","doi-asserted-by":"crossref","unstructured":"Ruiz-Bl\u00e1zquez, P, Pistorio, V, Fern\u00e1ndez-Fern\u00e1ndez, M, Moles, A. The multifaceted role of cathepsins in liver disease. J\u00a0Hepatol 2021;75:1192\u2013202. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.031.","DOI":"10.1016\/j.jhep.2021.06.031"},{"key":"2025122917011239157_j_biol-2025-1192_ref_051","doi-asserted-by":"crossref","unstructured":"Bao, W, Gu, Y, Chen, B, Yu, H. Golgi_DF: golgi proteins classification with deep forest. Front Neurosci 2023;17:1197824. https:\/\/doi.org\/10.3389\/fnins.2023.1197824.","DOI":"10.3389\/fnins.2023.1197824"},{"key":"2025122917011239157_j_biol-2025-1192_ref_052","doi-asserted-by":"crossref","unstructured":"Bao, W, Liu, Y, Chen, B. Oral_voting_transfer: classification of oral microorganisms\u2019 function proteins with voting transfer model. Front Microbiol 2023;14:1277121. https:\/\/doi.org\/10.3389\/fmicb.2023.1277121.","DOI":"10.3389\/fmicb.2023.1277121"},{"key":"2025122917011239157_j_biol-2025-1192_ref_053","doi-asserted-by":"crossref","unstructured":"Bao, W, Chen, B, Zhang, Y. WSHNN: a weakly supervised hybrid neural network for the identification of DNA-protein binding sites. Curr Comput Aided Drug Des 2024;21:599\u2013608. https:\/\/doi.org\/10.2174\/0115734099277249240129114123.","DOI":"10.2174\/0115734099277249240129114123"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1192\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1192\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:01:24Z","timestamp":1767027684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1192\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,1,27]]}},"alternative-id":["10.1515\/biol-2025-1192"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1192","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20251192"}}